Filip Małgorzata
Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, PL 31-343 Kraków, Poland.
Pharmacol Rep. 2005 Jan-Feb;57(1):35-46.
Previous studies have indicated a role of serotonin (5-HT)2 receptors in modulation of the behavioral effects of cocaine. In the present study, the efficacy of SR 46349B (a 5-HT(2A) receptor antagonist) or SDZ SER-082 (a 5-HT(2C) receptor antagonist) in altering cocaine seeking behavior was examined in rats. Rats were trained to press a lever for cocaine (0.5 mg/kg/infusion, iv) paired with the cue (light + tone). After stabilization of self-administration response, the animals underwent daily extinction sessions during which responding had no consequences. The cocaine seeking behavior was reinstated by cocaine priming (10 mg/kg, ip) or by presentation of the cue. Neither SR 46349B (0.25-1 mg/kg) nor SDZ SER-082 (0.25-1 mg/kg) altered the maintenance of cocaine self-administration. SR 46349B (0.5-1 mg/kg) decreased responding to the cocaine priming dose and reduced cue-induced reinstatement, while SDZ SER-082 failed to alter both cue- and cocaine priming-induced reinstatement. These findings indicate that 5-HT(2A) and 5-HT(2C) receptors are not significant to cocaine rewarding effects. However, they show the importance of the 5-HT(2A) receptors (but not 5-HT(2C) receptors) in cocaine-priming- and cue-provoked reinstatement. Since drugs that reduce cocaine seeking also alleviate cocaine craving, 5-HT(2A) receptor antagonists may be considered to be of possible clinical application for the treatment of cocaine dependence.
以往的研究表明,血清素(5-羟色胺,5-HT)2受体在调节可卡因的行为效应中发挥作用。在本研究中,研究了SR 46349B(一种5-HT(2A)受体拮抗剂)或SDZ SER-082(一种5-HT(2C)受体拮抗剂)改变大鼠可卡因觅求行为的效果。训练大鼠按压杠杆以获取与线索(灯光+音调)配对的可卡因(0.5毫克/千克/注射,静脉注射)。在自我给药反应稳定后,动物每天接受消退训练,在此期间反应没有结果。通过可卡因激发(10毫克/千克,腹腔注射)或呈现线索来恢复可卡因觅求行为。SR 46349B(0.25 - 1毫克/千克)和SDZ SER-082(0.25 - 1毫克/千克)均未改变可卡因自我给药的维持情况。SR 46349B(0.5 - 1毫克/千克)降低了对可卡因激发剂量的反应,并减少了线索诱导的复吸,而SDZ SER-082未能改变线索和可卡因激发诱导的复吸。这些发现表明,5-HT(2A)和5-HT(2C)受体对可卡因的奖赏效应并不重要。然而,它们显示了5-HT(2A)受体(而非5-HT(2C)受体)在可卡因激发和线索诱发的复吸中的重要性。由于减少可卡因觅求的药物也能减轻可卡因渴望,5-HT(2A)受体拮抗剂可能被认为在治疗可卡因依赖方面具有潜在的临床应用价值。